< Back to companies
Bioprognos

Bioprognos

Wilmington, Delaware, United States

Bioprognos is a spin-off of the Hospital Clínic of Barcelona (Barcelona, Catalonia), that seeks to improve clinical outcomes and quality of life for cancer ―as well as other conditions patients (with cardiovascular, neurological or endocrine disorders)―, by developing innovative, non-invasive, accurate, and cost-effective diagnostics solutions that give patients, doctors and payers the information they need from biomarkers found in a simple blood test (as well as urine and other body fluids).

Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
www.bioprognos.com/

Categories

DiagnosticsCancerBiomarker MonitoringCardiovascular Disease
Only accessible to MedStartr community members. Join now

What do you think of Bioprognos?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now